AT2101
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AT2101, covering 2010-08-19 to 2018-08-15. Get the full timeline:
Most recent: Clinical Trial Update: A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients [Phase 2]